NBIX — Neurocrine Biosciences Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as wel… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$155.83
Market Cap$15.64B
Float99.3M
Shares Outstanding100.5M
P/E (Forward)21.98
P/E (TTM)23.92
Price/Sales (TTM)5.04
vs. Analyst Target+22.6% to analyst PT
Profit Margin21.55%
Operating Margin (TTM)22.84%
Revenue (TTM)$3.10B
Earnings Growth (YoY)2310.50%
Dividend RateNone
Analyst Target Price$190.99 (25 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $1.05B $407M $1.04B $148M
2021 $1.13B $89.6M $1.12B $138M
2022 $1.49B $155M $1.47B $265M
2023 $1.89B $250M $1.85B $416M
2024 $2.36B $341M $2.32B $640M
2025 $2.86B $479M $2.81B $667M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $688M $108M
Sep 2025 $795M $210M
Dec 2025 $806M $154M
Mar 2026 $815M $198M

Ownership & Float

Insider Ownership1.1%
Institutional Ownership103.4%
Short Float6.0%
% of All Funds Holding7.95%
Number of Funds Holding653

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$140.47Near-term / short-term trend
Weekly40-Week SMA$140.03Medium-term trend
Weekly80-Week SMA$132.09Cyclical trend (business cycle)
Weekly200-Week SMA$123.50Secular trend (multi-year)
Monthly10-Month SMA$140.47Near-term monthly trend
Monthly20-Month SMA$132.70Medium-term monthly trend
Monthly40-Month SMA$125.71Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$132.00 support 1.05x 0 months ago
$108.00 support 1.31x 11 months ago

Historical Earnings Reactions (120 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.03% 0.00% 48.33% 16.61% -30.37%
1 Day -0.41% -0.69% 41.67% 19.45% -30.01%
1 Week 0.62% 0.37% 50.83% 24.51% -23.58%
2 Weeks 1.28% -0.29% 49.17% 30.30% -28.91%
1 Month 2.29% 1.34% 57.14% 139.29% -69.47%

Next earnings: July 24, 2026 (57 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan6.4%50.0%30
Feb-1.5%30.0%30
Mar-0.9%40.0%30
Apr-1.2%33.3%30
May4.9%58.6%29
Jun2.0%53.3%30
Jul-0.2%50.0%30
Aug2.3%53.3%30
Sep2.7%56.7%30
Oct3.0%56.7%30
Nov3.9%60.0%30
Dec4.0%63.3%30

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.16% 46.2% 1419
Tuesday 0.11% 48.9% 1551
Wednesday 0.15% 49.3% 1548
Thursday 0.15% 48.8% 1517
Friday 0.27% 51.6% 1513

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 103.4%

Insider Transactions — Smart Summary

Total insider ownership: 1.1%

12-Month Insider Activity Summary

Total Filings16
Net Value-$8.4M
Net Shares Change-49,300
% of Float-0.0%
C-Suite Filings7
Clusters Detected2

Key Insiders

NameTitleNet ValueFilingsActivity
GORMAN KEVIN CHARLES -$38.6M 2 N/A
Gano Kyle Chief Executive Officer -$3.5M 1 N/A
Onyia Jude Chief Scientific Officer -$2.7M 1 N/A
RASTETTER WILLIAM H -$1.9M 1 N/A
POPS RICHARD F -$1.6M 1 N/A
LYONS GARY A -$1.6M 1 N/A
MORROW GEORGE J -$1.4M 1 N/A
Norwalk Leslie V -$625,561.064 2 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-11-26 – 2025-12-10 4 4 -$4.2M 2 C-suite
2026-05-14 – 2026-05-21 3 3 -$31.2M

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-05-14 Norwalk Leslie V -$590,601.054 Transaction at $155.01, now +0.5%
2026-05-21 GORMAN KEVIN CHARLES -$29.0M Transaction at $98.79, now +57.7%
2025-12-17 Norwalk Leslie V -$34,960.01 Transaction at $121.93, now +27.8%
2026-05-18 POPS RICHARD F -$1.6M Transaction at $102.77, now +51.6%
2026-01-20 Gano Kyle Chief Executive Officer -$3.5M Transaction at $84.35, now +84.7%
2025-08-11 GORMAN KEVIN CHARLES -$9.6M Transaction at $81.20, now +91.9%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Neurocrine Biosciences Inc (NBIX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for NBIX on Trend Edge →